View Older Stories View More Recent Stories

Jun 28, 2017 04:15PM Aethlon Medical Announces Fiscal 2017 Results
Jun 26, 2017 08:15AM Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017
Jun 14, 2017 08:00AM Aethlon Medical To Present Clinical Study Results at The BIO International Convention
Jun 6, 2017 08:00AM Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017
May 24, 2017 08:00AM Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017
Apr 24, 2017 09:25AM Aethlon Medical Releases Shareholder Update
Apr 4, 2017 09:03AM Aethlon Medical Discloses Tech Nation Interview On National Public Radio
Mar 13, 2017 07:17AM Aethlon Medical (AEMD) Concludes Hemopurifier Clinical Study
Mar 13, 2017 07:15AM Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study
Mar 8, 2017 09:25AM Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017
Mar 1, 2017 09:26AM Aethlon Medical (AEMD) Reports European Patent Protecting Methods of Quantifying Exosomes
Mar 1, 2017 09:25AM Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes
Feb 24, 2017 09:25AM Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism
Feb 22, 2017 09:30AM Aethlon Medical (AEMD) Says Results of Study Show Ability of Aethlon Hemopurifier to Capture Latent Viral Pathogens
Feb 22, 2017 09:25AM Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies
Feb 10, 2017 04:15PM Aethlon Medical Announces Fiscal 2017 Third Quarter Results
Feb 6, 2017 09:25AM Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017
Jan 25, 2017 07:00AM Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players
Jan 11, 2017 09:12AM CEO Note - Clinical Study Update and a Review of 2016 Accomplishments
Dec 21, 2016 09:25AM Passage of the 21st Century Cures Act and its Potential Implications on Biodefense
Dec 15, 2016 09:29AM Aethlon Medical (AEMD) Initiates Research Study to Validate Ability of Aethlon Hemopurifier to Capture Viruses in Sepsis Patients
Dec 15, 2016 09:25AM Aethlon Announces Initiation of Sepsis-Related Virus Study
Nov 10, 2016 04:15PM Aethlon Medical Announces Fiscal 2017 Second Quarter Results
Nov 3, 2016 09:25AM Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016
Oct 13, 2016 09:12AM Aethlon Medical (AEMD) Announces Completion of Multiple DARPA Milestones
Oct 13, 2016 09:11AM Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation
Oct 12, 2016 09:25AM Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum
Sep 20, 2016 09:25AM Aethlon Medical Updates Corporate Presentation Schedule
Sep 12, 2016 09:25AM Aethlon Medical To Present At The Rodman & Renshaw 18th Annual Global Investment Conference On September 13, 2016
Sep 9, 2016 09:09AM The Dilemma in Funding Zika and Other Pandemic Therapies
Sep 9, 2016 09:09AM The Dilemma in Funding Zika and Other Pandemic Therapies
Sep 6, 2016 09:25AM Aethlon Medical Announces Upcoming September Investor And Industry Conferences
Sep 6, 2016 09:25AM Aethlon Medical Announces Upcoming September Investor And Industry Conferences
Aug 11, 2016 04:15PM Aethlon Medical Announces Fiscal 2017 First Quarter Results
Aug 11, 2016 09:13AM Aethlon Medical (AEMD) Announces Positive Hemopurifier in vitro Study Data in Zika Virus
Aug 11, 2016 09:12AM Aethlon Medical Announces Zika Virus Data
Aug 9, 2016 12:07PM Aethlon Medical To Host First Quarter Fiscal 2017 Investor Call On August 11, 2016
Jun 29, 2016 04:15PM Aethlon Medical Announces Fiscal 2016 Results
Jun 28, 2016 09:19AM Aethlon Medical (AEMD) Files for $12.5M Common Stock At The Market Sales Program
Jun 28, 2016 09:15AM Aethlon Medical Announces $12.5 Million At The Market Program
Jun 27, 2016 09:45AM Aethlon Medical Joins Russell Microcap® Index
Jun 27, 2016 09:15AM Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016
Jun 22, 2016 09:15AM Aethlon Medical Set To Join Russell Microcap® Index
Jun 14, 2016 10:28AM Aethlon Medical Announces Issuance Of Exosome Capture Patent
Jun 6, 2016 09:30AM Aethlon Medical To Present Cancer And Infectious Disease Initiatives, As Well As Chronic Traumatic Encephalopathy (CTE) Candidate Biomarker Discovery At Tomorrow's BIO International Convention
Jun 1, 2016 09:30AM Aethlon Medical To Present At 2nd Annual Sachs Associates Immuno-oncology: BD&L And Investment Forum On June 3, 2016
May 4, 2016 09:30AM Aethlon Medical's Exosome Sciences Announces Production of ELLSA Exosome Isolation Platform
May 2, 2016 08:45AM Aethlon Medical (AEMD) CEO Note: Hemopurifier Clinical Progression, USA Today on the Next Zika, Combating Bioterror & Pandemic Threats
Mar 31, 2016 09:34AM Aethlon Medical (AEMD) Discloses Hemopurifier Trial and Manufacturing Advancements, Says Study Back on Track
Mar 31, 2016 09:30AM Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements
View More Recent Stories View Older Stories